Chris Schneider

Senior Scientist II Novo Nordisk

Seminars

Thursday 1st October 2026
Panel: Embedding Biocatalysis Upstream, When Does It Add Value & How Do You Make It Stick?
12:10 pm
  • When is the right stage to introduce biocatalysis in the development pipeline?
  • How are organizations balancing early investment with high attrition risk?
  • What has worked (and failed) when trying to shift from late-stage to early-stage adoption?
  • How do you align chemists, biologists, and process teams around a shared approach?
Chris Schneider